Insulin and hypertension in the NHLBI family heart study

American Journal of Hypertension

Volumn 13, Issue 3, 2000, Pages 240-250

  Kronenberg, Florian ^a   Rich, Stephen S ^b   Sholinsky, Phyliss ^c   Arnett, Donna K ^d   Province, Michael E ^e   Myers, Richard H ^f   Eckfeldt, John H ^g   Williams, Roger R ^a   Hunt, Steven C ^a  

^a UNIVERSITY OF UTAH   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e WASHINGTON UNIVERSITY   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

Author keywords

Body mass index; Hypertension; Insulin; Obesity; Sibpair study

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; ENVIRONMENTAL FACTOR; FEMALE; GENETIC VARIABILITY; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MULTICENTER STUDY; OBESITY; PRIORITY JOURNAL; SIBLING; SYSTOLIC HYPERTENSION;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; COHORT STUDIES; DIASTOLE; FEMALE; HUMANS; HYPERTENSION; INSULIN; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATIONAL INSTITUTES OF HEALTH (U.S.); NUCLEAR FAMILY; SYSTOLE; UNITED STATES;

EID: 0034035846     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00177-6     Document Type: Article

References (57)

1. Hopkins P.N., Hunt S.C., Wu L.L., Williams G.H., Williams R.R. Hypertension, dyslipidemia, and insulin resistance links in a chain or spokes on a wheel? Curr Opin Lipidol. 7:1996;241-253.
2. Welborn T.A., Breckenridge A., Rubinstein A.H., Dollery C.T., Fraser T.R. Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet. 1:1966;1336-1337.
3. Pollare T., Lithell H., Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism. 39:1990;167-174.
4. Williams RR, Hunt SC, Schumacher MC, Hopkins PN, Wu LL, Barlow GK, Stults BM, Wilson DE, Lalouel J-M: Genes, hypertension and coronary heart disease: evidence for shared metabolic pathophysiology, in Smith et al. (eds): Hypertension as an Insulin-Resistant Disorder. Genetic Factors and Cellular Mechanisms. The Netherlands, Excerpta Medica, 1991, pp 89-101.
5. Skarfors E.T., Lithell H.O., Selinus I. Risk factors for the development of hypertension a 10-year longitudinal study in middle-aged men . J Hypertens. 9:1991;217-223.
6. Modan M., Halkin H., Almog S., Lusky A., Eshkol A., Shefi M., Shitrit A., Fuchs Z. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest. 75:1985;809-817.
7. Nilsson P., Lindholm L., Schersten B. Hyperinsulinaemia and other metabolic disturbances in well- controlled hypertensive men and women an epidemiological study of the Dalby population . J Hypertens. 8:1990;953-959.
8. Lind L., Lithell H., Pollare T. Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors? J Hypertens. 11:(suppl):1993;. 4):S11-. 4):S16.
9. Yamada N., Yoshinaga H., Sakurai N., Shimano H., Gotoda T., Ohashi Y., Yazaki Y., Kosaka K. Increased risk factors for coronary artery disease in Japanese subjects with hyperinsulinemia or glucose intolerance. Diabetes Care. 17:1994;107-114.
10. Ohmori S., Kiyohara Y., Kato I., Ohmura T., Iwamoto H., Nakayama K., Nomiyama K., Yoshitake T., Ueda K., Fujishima M. Hyperinsulinaemia and blood pressure in a general Japanese population:the Hisayama Study. J Hypertens. 12:1994;1191-1197.
11. Ward K.D., Sparrow D., Landsberg L., Young J.B., Vokonas P.S., Weiss S.T. Influence of insulin, sympathetic nervous system activity, and obesity on blood pressure the Normative Aging Study . J Hypertens. 14:1996;301-308.
12. Chan J.C., Cheung J.C., Lau E.M., Wooa J., Chan A.Y., Swaminathan R., Cockrama C.S. The metabolic syndrome in Hong Kong Chinese. The interrelationships among its components analyzed by structural equation modeling. Diabetes Care. 19:1996;953-959.
13. Haffner S.M., Miettinen H., Gaskill S.P., Stern M.P. Metabolic precursors of hypertension. The San Antonio Heart Study. Arch Intern Med. 156:1996;1994-2001.
14. Masuo K., Mikami H., Ogihara T., Tuck M.L. Prevalence of hyperinsulinemia in young, nonobese Japanese men. J Hypertens. 15:1997;157-165.
15. Ferreira S.R., Franco L.J., Gimeno S.G., Iochida L.C., Iunes M. Is insulin or its precursor independently associated with hypertension? An epidemiological study in Japanese-Brazilians. Hypertension. 30:1997;641-645.
16. Manolio T.A., Savage P.J., Burke G.L., Liu K.A., Wagenknecht L.E., Sidney S., Jacobs D.R. Jr, Roseman J.M., Donahue R.P., Oberman A. Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study. Arteriosclerosis. 10:1990;430-436.
17. Asch S., Wingard D.L., Barrett-Connor E.L. Are insulin and hypertension independently related? Ann Epidemiol. 1:1991;231-244.
18. Collins V.R., Dowse G.K., Finch C.F., Zimmet P.Z. An inconsistent relationship between insulin and blood pressure in three Pacific island populations. J Clin Epidemiol. 43:1990;1369-1378.
19. Feskens E.J., Kromhout D. Hyperinsulinemia, risk factors, and coronary heart disease. The Zutphen Elderly Study. Arterioscler Thromb. 14:1994;1641-1647.
20. Mitchell B.D., Haffner S.M., Hazuda H.P., Valdez R., Stern M.P. The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels. Am J Epidemiol. 136:1992;12-22.
21. Neel J.V., Julius S., Weder A., Yamada M., Kardia S.L., Haviland M.B. Syndrome X is it for real? Genet Epidemiol. 15:1998;19-32.
22. Schmidt M.I., Watson R.L., Duncan B.B., Metcalf P., Brancati F.L., Sharrett A.R., Davis C.E., Heiss G. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism. 45:1996;699-706.
23. Cambien F., Warnet J.M., Eschwege E., Jacqueson A., Richard J.L., Rosselin G. Body mass, blood pressure, glucose, and lipids. Does plasma insulin explain their relationships? Arteriosclerosis. 7:1987;197-202.
24. Grugni G., Ardizzi A., Dubini A., Guzzaloni G., Sartorio A., Morabito F. No correlation between insulin levels and high blood pressure in obese subjects. Horm Metab Res. 22:1990;124-125.
25. Weisser B., Grune S., Spuhler T., Kistler T., Vetter W. Plasma insulin is correlated with blood pressure only in subjects with a family history of hypertension or diabetes mellitus results from 11,001 participants in the Heureka Study . J Hypertens. 11:(suppl 5):1993;S308-S309.
26. Dowse G.K., Collins V.R., Alberti K.G., Zimmet P.Z., Tuomilehto J., Chitson P., Gareeboo H. Insulin and blood pressure levels are not independently related in Mauritians of Asian Indian, Creole or Chinese origin. The Mauritius Non-communicable Disease Study Group. J Hypertens. 11:1993;297-307.
27. Heise T., Magnusson K., Heinemann L., Sawicki P.T. Insulin resistance and the effect of insulin on blood pressure in essential hypertension. Hypertension. 32:1998;243-248.
28. Bunker C.H., Ukoli F.A., Matthews K.A., Kriska A.M., Huston S.L., Kuller L.H. Weight threshold and blood pressure in a lean black population. Hypertension. 26:1995;616-623.
29. Rosmond R., Bjorntorp P. Blood pressure in relation to obesity, insulin and the hypothalamic-pituitary-adrenal axis in Swedish men. J Hypertens. 16:1998;1721-1726.
30. Wannamethee S.G., Shaper A.G., Durrington P.N., Perry I.J. Hypertension, serum insulin, obesity and the metabolic syndrome. J Hum Hypertens. 12:1998;735-741.
31. Stamler R., Stamler J., Riedlinger W.F., Algera G., Roberts R.H. Weight and blood pressure. Findings in hypertension screening of 1 million Americans. AMA. 240:1978;1607-1610.
32. Jacob S., Rett K., Henriksen E.J. Antihypertensive therapy and insulin sensitivity do we have to redefine the role of beta-blocking agents? Am J Hypertens. 11:1998;1258-1265.
33. Mayer E.J., Newman B., Austin M.A., Zhang D., Quesenberry C.P. Jr, Edwards K., Selby J.V. Genetic and environmental influences on insulin levels and the insulin resistance syndrome an analysis of women twins . Am J Epidemiol. 143:1996;323-332.
34. Hong Y., Pedersen N.L., Brismar K., De Faire U. Genetic and environmental architecture of the features of the insulin- resistance syndrome. Am J Hum Genet. 60:1997;143-152.
35. Higgins M., Province M., Heiss G., Eckfeldt J., Ellison R.C., Folsom A.R., Rao D.C., Sprafka M., Williams R. NHLBI Family Heart Study: objectives and design. Am J Epidemiol. 143:1996;1219-1228.
36. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-2446.
37. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man . Diabetologia. 28:1985;412-419.
38. Howard G., Bergman R., Wagenknecht L.E., Haffner S.M., Savage P.J., Saad M.F., Laws A., D'Agostino R.B. Jr. Ability of alternative indices of insulin sensitivity to predict cardiovascular risk comparison with the "minimal model." Insulin Resistance Atherosclerosis Study (IRAS) Investigators . Ann Epidemiol. 8:1998;358-369.
39. Rowe J.W., Young J.B., Minaker K.L., Stevens A.L., Pallotta J., Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 30:1981;219-225.
40. Goldstein D.S. Plasma catecholamines and essential hypertension. An analytical review. Hypertension. 5:1983;86-99.
41. DeFronzo R.A. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia. 21:1981;165-171.
42. Leonetti F., Iozzo P., Giaccari A., Sbraccia P., Buongiorno A., Tamburrano G., Andreani D. Absence of clinically overt atherosclerotic vascular disease and adverse changes in cardiovascular risk factors in 70 patients with insulinoma. J Endocrinol Invest. 16:1993;875-880.
43. Anderson E.A., Hoffman R.P., Balon T.W., Sinkey C.A., Mark A.L. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 87:1991;2246-2252.
44. Anderson E.A., Balon T.W., Hoffman R.P., Sinkey C.A., Mark A.L. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension. 19:1992;621-627.
45. Hall J.E., Brands M.W., Zappe D.H., Alonso Galicia M. Insulin resistance, hyperinsulinemia, and hypertension causes, consequences, or merely correlations? Proc Soc Exp Biol Med. 208:1995;317-329.
46. Saad M.F., Knowler W.C., Pettitt D.J., Nelson R.G., Mott D.M., Bennett P.H. Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians. Diabetes. 39:1990;1430-1435.
47. Mehrabian M., Wen P.Z., Fisler J., Davis R.C., Lusis A.J. Genetic loci controlling body fat, lipoprotein metabolism, and insulin levels in a multifactorial mouse model. J Clin Invest. 101:1998;2485-2496.
48. Wolf H.K., Tuomilehto J., Kuulasmaa K., Domarkiene S., Cepaitis Z., Molarius A., Sans S., Dobson A., Keil U., Rywik S. Blood pressure levels in the 41 populations of the WHO MONICA Project. J Hum Hypertens. 11:1997;733-742.
49. Stanton J.L., Braitman L.E., Riley A.M. Jr, Khoo C.S., Smith J.L. Demographic, dietary, life style, and anthropometric correlates of blood pressure. Hypertension. 4:1982;III135-III142.
50. Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M.A., Oleggini M., Graziadei L., Pedrinelli R., Brandi L., Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 317:1987;350-357.
51. Muller D.C., Elahi D., Pratley R.E., Tobin J.D., Andres R. An epidemiological test of the hyperinsulinemia-hypertension hypothesis. J Clin Endocrinol Metab. 76:1993;544-548.
52. Shetterly S.M., Rewers M., Hamman R.F., Marshall J.A. Patterns and predictors of hypertension incidence among Hispanics and non-Hispanic whites the San Luis Valley Diabetes Study . J Hypertens. 12:1994;1095-1102.
53. Fagot-Campagna A., Balkau B., Simon D., Ducimetiere P., Eschwege E. Is insulin an independent risk factor for hypertension? The Paris Prospective Study. Int J Epidemiol. 26:1997;542-550.
54. He J., Klag M.J., Caballero B., Appel L.J., Charleston J., Whelton P.K. Plasma insulin levels and incidence of hypertension in African Americans and whites. Arch Intern Med. 159:1999;498-503.
55. Everson S.A., Goldberg D.E., Helmrich S.P., Lakka T.A., Lynch J.W., Kaplan G.A., Salonen J.T. Weight gain and the risk of developing insulin resistance syndrome. Diabetes Care. 21:1998;1637-1643.
56. Lissner L., Bengtsson C., Lapidus L., Kristjansson K., Wedel H. Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension. 20:1992;797-801.
57. Salonen J.T., Lakka T.A., Lakka H.M., Valkonen V.P., Everson S.A., Kaplan G.A. Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes. 47:1998;270-275.